Co-Founder of Prismic Pharmaceuticals
Zachary Dutton joined FSD Pharma in July 2019 following the acquisition of Prismic Pharmaceuticals, where he was its CEO. Mr. Dutton is a multifunctional healthcare professional and leader with over 20 years business and entrepreneurial experience with a focus on corporate development, partnerships and strategic planning. He has broad experience within healthcare and has held senior positions in multiple sectors including prescription drugs, medical foods and dietary supplements.
Prior to founding Prismic Pharmaceuticals in 2011, Mr. Dutton held positions in several emerging companies including Primus Pharmaceuticals, a pioneer in the medical food space, where his responsibilities included business development, marketing and strategic planning and Emerge Pharma, a corporate development consulting firm he founded, where he completed multiple international licensing transactions.
He holds an Honors Bachelor of Arts from Queen’s University and received his MBA from the F.W. Olin School of Business at Babson College.